Advertisement
Screener

PROFOUND MEDICAL CORP. (PROF) Total Long-Term Debt

2.8 / 5 stars · 68/120 Roast Me

PROFOUND MEDICAL CORP. Total Long-Term Debt

PROFOUND MEDICAL CORP. (PROF) had Total Long-Term Debt of $4.51 million as of 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Balance Sheet › Liabilities

us-gaap:LongTermDebt · last filed 2026-08-06

  • 2026-06-30: Long-term Debt $4.51M.
  • 2026-03-31: Long-term Debt $4.50M.
  • 2025-12-31: Long-term Debt $4.50M.
  • 2025-09-30: Long-term Debt $4.48M.
Period endLong-term Debt
2026-06-30$4.51M
10-Q · filed 2026-08-06
2026-03-31$4.50M
10-Q · filed 2026-05-07
2025-12-31$4.50M
10-Q · filed 2026-08-06
2025-09-30$4.48M
10-Q · filed 2025-11-13
2025-06-30$4.46M
10-Q · filed 2025-08-14
2025-03-31$4.49M
10-Q · filed 2025-05-08
2024-12-31$4.66M
10-Q · filed 2026-08-06
2023-12-31$7.10M
10-K · filed 2026-03-05
2022-12-31$7.17M
10-K · filed 2025-03-07

Similar stocks

Stock NameCountryMarket CapPE Ratio
Neuronetics, Inc. (STIM)United States$0.216B-3.25
PRO DEX INC (PDEX)United States$0.234B13.64
UTAH MEDICAL PRODUCTS INC (UTMD)United States$0.238B20.93
Lucid Diagnostics Inc. (LUCD)United States$0.170B
InfuSystem Holdings, Inc (INFU)United States$0.253B22.52
KORU Medical Systems, Inc. (KRMD)United States$0.151B-106.78
Anika Therapeutics, Inc. (ANIK)United States$0.272B-51.71
ORASURE TECHNOLOGIES INC (OSUR)United States$0.272B-6.26
Cytosorbents Corp (CTSO)United States$0.274B-1.29
TriSalus Life Sciences, Inc. (TLSI)United States$0.283B-9.92